Observational studyAnnals of transplantation2023

Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience.

Masato Shizuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.